HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Amy E Bock Selected Research

Methotrexate (Mexate)

1/2018A comparative clinical study of PF-06410293, a candidate adalimumab biosimilar, and adalimumab reference product (Humira®) in the treatment of active rheumatoid arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Amy E Bock Research Topics

Disease

5Rheumatoid Arthritis
06/2022 - 01/2018
2Injection Site Reaction
10/2021 - 01/2018
1Myocardial Infarction
01/2018
1Opportunistic Infections (Opportunistic Infection)
01/2018
1Pneumonia (Pneumonitis)
01/2018
1Rheumatic Diseases (Rheumatism)
01/2018
1Hypersensitivity (Allergy)
01/2018

Drug/Important Bio-Agent (IBA)

5Biosimilar PharmaceuticalsIBA
06/2022 - 01/2018
5Adalimumab (Humira)FDA Link
06/2022 - 01/2018
4PF-06410293IBA
06/2022 - 01/2018
1Infliximab (Remicade)FDA Link
01/2022
13-benzoyl dopamine (MBDA)IBA
01/2022
1Methotrexate (Mexate)FDA LinkGeneric
01/2018
1C-Reactive ProteinIBA
01/2018

Therapy/Procedure

4Activities of Daily Living (ADL)
06/2022 - 01/2021
1Therapeutics
01/2021